| pubmed-article:2290807 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2290807 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:2290807 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:2290807 | lifeskim:mentions | umls-concept:C0041327 | lld:lifeskim |
| pubmed-article:2290807 | lifeskim:mentions | umls-concept:C0376315 | lld:lifeskim |
| pubmed-article:2290807 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:2290807 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:2290807 | pubmed:dateCreated | 1991-4-4 | lld:pubmed |
| pubmed-article:2290807 | pubmed:abstractText | Observation findings concerning 112 adolescents with tuberculosis are presented. The patients were divided into 2 groups. Group 1 included 61 cases with primary forms of tuberculosis and without lung tissue destruction or bacillary excretion. The best part of this group was affected by tuberculosis of intrathoracic lymph nodes and focal tuberculosis. Group 2 consisted of 51 patients with primary tuberculosis in addition to lung tissue destruction or bacillary excretion. Most of these patients had infiltrative tuberculosis. Their treatment regimens were standard ones. The patients of group 1 are recommended to have a 6-month hospital management and a subsequent additional treatment at a sanatorium for 3 months. The period of the in-patient chemotherapy of group 2 should be no less than 9 months plus 3 months of additional treatment at a sanatorium. | lld:pubmed |
| pubmed-article:2290807 | pubmed:language | rus | lld:pubmed |
| pubmed-article:2290807 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2290807 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2290807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2290807 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2290807 | pubmed:issn | 0032-9533 | lld:pubmed |
| pubmed-article:2290807 | pubmed:author | pubmed-author:IanchevskaiaA... | lld:pubmed |
| pubmed-article:2290807 | pubmed:author | pubmed-author:FirsovaV AVA | lld:pubmed |
| pubmed-article:2290807 | pubmed:author | pubmed-author:OvsiankinaE... | lld:pubmed |
| pubmed-article:2290807 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2290807 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2290807 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2290807 | pubmed:pagination | 21-3 | lld:pubmed |
| pubmed-article:2290807 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2290807 | pubmed:meshHeading | pubmed-meshheading:2290807-... | lld:pubmed |
| pubmed-article:2290807 | pubmed:meshHeading | pubmed-meshheading:2290807-... | lld:pubmed |
| pubmed-article:2290807 | pubmed:meshHeading | pubmed-meshheading:2290807-... | lld:pubmed |
| pubmed-article:2290807 | pubmed:meshHeading | pubmed-meshheading:2290807-... | lld:pubmed |
| pubmed-article:2290807 | pubmed:meshHeading | pubmed-meshheading:2290807-... | lld:pubmed |
| pubmed-article:2290807 | pubmed:meshHeading | pubmed-meshheading:2290807-... | lld:pubmed |
| pubmed-article:2290807 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2290807 | pubmed:articleTitle | [Improvement of chemotherapy of primary forms of pulmonary tuberculosis in adolescents]. | lld:pubmed |
| pubmed-article:2290807 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2290807 | pubmed:publicationType | English Abstract | lld:pubmed |
